112 related articles for article (PubMed ID: 17230597)
1. Pharmacokinetics of 5-fluorouracil in mutant Nagase analbuminemic rats: faster metabolism of 5-fluorouracil via CYP1A.
Choi YH; Bae SK; Kim SO; Lee MG
Biopharm Drug Dispos; 2007 Mar; 28(2):87-95. PubMed ID: 17230597
[TBL] [Abstract][Full Text] [Related]
2. Effects of CYP inducers and inhibitors on the pharmacokinetics of intravenous theophylline in rats: involvement of CYP1A1/2 in the formation of 1,3-DMU.
Yang KH; Lee JH; Lee MG
J Pharm Pharmacol; 2008 Jan; 60(1):45-53. PubMed ID: 18088504
[TBL] [Abstract][Full Text] [Related]
3. Faster clearance of omeprazole in mutant Nagase analbuminemic rats: possible roles of increased protein expression of hepatic CYP1A2 and lower plasma protein binding.
Lee DY; Jung YS; Kim YC; Kim SY; Lee MG
Biopharm Drug Dispos; 2009 Apr; 30(3):107-16. PubMed ID: 19288444
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of oltipraz in mutant Nagase analbuminemic rats.
Bae SK; Kang HE; Kang MK; Kim JW; Kim T; Lee MG
J Pharm Sci; 2006 May; 95(5):998-1005. PubMed ID: 16544321
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of intravenous methotrexate in mutant Nagase analbuminemic rats.
Choi YH; Bae SK; Oh JM; Kim SO; Lee MG
Biopharm Drug Dispos; 2007 Oct; 28(7):385-92. PubMed ID: 17657787
[TBL] [Abstract][Full Text] [Related]
6. Ipriflavone pharmacokinetics in mutant Nagase analbuminemic rats.
Chung HJ; Kang HE; Yang KH; Kim SY; Lee MG
Biopharm Drug Dispos; 2009 Sep; 30(6):294-304. PubMed ID: 19591122
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of intravenous theophylline in mutant Nagase analbuminemic rats.
Kim EJ; Suh OK; Lee MG
Life Sci; 2003 Jan; 72(11):1231-45. PubMed ID: 12570924
[TBL] [Abstract][Full Text] [Related]
8. Effects of cytochrome P450 inducers and inhibitors on the pharmacokinetics of intravenous furosemide in rats: involvement of CYP2C11, 2E1, 3A1 and 3A2 in furosemide metabolism.
Yang KH; Choi YH; Lee U; Lee JH; Lee MG
J Pharm Pharmacol; 2009 Jan; 61(1):47-54. PubMed ID: 19126296
[TBL] [Abstract][Full Text] [Related]
9. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous omeprazole in rats.
Lee DY; Shin HS; Bae SK; Lee MG
Biopharm Drug Dispos; 2006 Jul; 27(5):209-18. PubMed ID: 16586464
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of 5-fluorouracil in rats with diabetes mellitus induced by streptozotocin.
Choi YH; Lee AK; Bae SK; Kim SO; Lee MG
Biopharm Drug Dispos; 2005 Apr; 26(3):93-8. PubMed ID: 15674819
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of intravenous azosemide in mutant Nagase analbuminemic rats.
Kim EJ; Lee AK; Kim SH; Kim SG; Lee MG
Drug Metab Dispos; 2003 Feb; 31(2):194-201. PubMed ID: 12527700
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of intravenous bumetanide in mutant Nagase analbuminemic rats: importance of globulin binding for the pharmacodynamic effects.
Kim EJ; Lee MG
Biopharm Drug Dispos; 2001 May; 22(4):147-56. PubMed ID: 11745917
[TBL] [Abstract][Full Text] [Related]
13. Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous theophylline in rats: the role of CYP2E1 induction in 1,3-dimethyluric acid formation.
Yu SY; Chung HC; Kim EJ; Kim SH; Lee I; Kim SG; Lee MG
J Pharm Pharmacol; 2002 Dec; 54(12):1687-92. PubMed ID: 12542900
[TBL] [Abstract][Full Text] [Related]
14. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous ipriflavone in rats.
Chung HJ; Choi YH; Kim SH; Lee MG
J Pharm Pharmacol; 2006 Apr; 58(4):449-57. PubMed ID: 16597362
[TBL] [Abstract][Full Text] [Related]
15. The effect of infliximab on hepatic cytochrome P450 and pharmacokinetics of verapamil in rats with pre-adjuvant arthritis: a drug-disease and drug-drug interaction.
Ling S; Jamali F
Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):24-9. PubMed ID: 19371259
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of intravenous trasemide in mutant Nagase analbuminemic rats.
Kim EJ; Lee MG
Biopharm Drug Dispos; 2003 Jan; 24(1):27-35. PubMed ID: 12516076
[TBL] [Abstract][Full Text] [Related]
17. Faster clearance of omeprazole in rats with acute renal failure induced by uranyl nitrate: contribution of increased expression of hepatic cytochrome P450 (CYP) 3A1 and intestinal CYP1A and 3A subfamilies.
Lee DY; Jung YS; Shin HS; Lee I; Kim YC; Lee MG
J Pharm Pharmacol; 2008 Jul; 60(7):843-51. PubMed ID: 18549670
[TBL] [Abstract][Full Text] [Related]
18. Alteration of the pharmacokinetics of theophylline by rutaecarpine, an alkaloid of the medicinal herb Evodia rutaecarpa, in rats.
Ueng YF; Tsai TH; Don MJ; Chen RM; Chen TL
J Pharm Pharmacol; 2005 Feb; 57(2):227-32. PubMed ID: 15720787
[TBL] [Abstract][Full Text] [Related]
19. Effects of neostigmine on the pharmacokinetics of intravenous parathion in rats.
Hurh E; Lee EJ; Kim YG; Kim SY; Kim SH; Kim YC; Lee MG
Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):261-73. PubMed ID: 11913717
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic changes of intravenous 2-(allylthio) pyrazine, a chemoprotective agent, in rats with acute renal failure induced by uranyl nitrate.
Lee EJ; Kim EJ; Kim YG; Chung HC; Kim SH; Kim DH; Lee I; Kim SG; Lee MG
Res Commun Mol Pathol Pharmacol; 2002; 111(5-6):225-36. PubMed ID: 15244038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
